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Summary.-Malignant effusions and tumour tissue obtained at surgery provided
material for a study of the prognostic value of the various inflammatory cells in the
prognosis of human ovarian cancer. Ascitic fluids predominantly contained in-
flammatory cells; tumour cells, both singly and in clusters, were a minor component.
Tumour cells were usually in excess in dispersed solid material. Some patients had
significant proportions of lymphocytes and macrophages in their solid tumour, and
these patients invariably responded to therapy. Sedimentation-velocity separation
at unit gravity provided two populations of inflammatory cells. One consisted of
mononuclear cells similar in size to those in the patients blood: the other con-
sisted of one or more large macrophage populations, distinct in morphology and
enzymatic markers from both blood monocytes and each other. T lymphocytes
were enriched in ascites fractions (78%) and in the tumour-derived mononuclear
fraction (71%) compared to patient blood (60%). The T-cell subset characterized
by ANAE reactivity was markedly depleted in the tumour-infiltrating fraction
(17%) relative to either the ascites (62%) or patient blood (51°/,). Esterase-positive
monocyte-like cells weremorefrequent inthe tumour-infiltrating fraction (17%) than
in ascites (7%) or blood (12%). B lymphocytes were infrequent in solid tumours
and difficult to assess in ascites. Histiocyte-like macrophages were present in the
higher-velocity tumour-cell containing fractions of both solid and ascitic material.
The variation in infiltrating cells between patients and between tumour and ascites
of the same individual was marked.
OVARIAN CANCER is the foremost gynae-
coligical cause of death from cancer.
Survival after surgery depends upon a
multitude of factors, including residual
tumour burden, degree of differentiation
and staging (Newman et al., 1980).
Little is known about the possible rele-
vance of mononuclear-cell infiltration to
patient survival. Although there is a
consensus that, for a variety of cancers
in situ, immunity may be important to
clinical response (Underwood, 1974; loa-
chim, 1976), there has yet to be a study
which directly implicates immune-depen-
dent cellular mechanisms ingrowth control
of cancer. Recently, a number of reports
have described attempts to characterize
the immunological competence oflympho-
cytes or macrophages isolated from human
cancers or ascites (Mantovani et al.,
1979; Werkmeister et al., 1979; Totterman
et al., 1980; Klein et al., 1980; Herberman
et al., 1980; Vose, 1978).
We have initiated a programme designed
to assess the relevance of mononuclear-
cell infiltration to the prognosis ofpatients
with cancer of the ovary. In this first
report, we will describe the methodology
which we have used to fractionate both
ascites and solid material into two basic
fractions. In subsequent studies, these
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contrast the activity of blood-derived,
ascites, and tumour-associated lympho-
cytes and macrophages.
MATERIAL AND METHODS
Human subjects.-Thirty-eight patients
with histologically confirmed epithelial cancer
of the ovary were used in this study. All but
one were classified as Stages III or IV. Most
patients provided both ascites and solid
tumour material for analysis. In several cases,
both ovarian and omental tumours were
obtained. Because surgical removal of the
ovary left only the extensive omental tumour
to be treated, this tissue was used, when
available, for analysis as it represented the
target forfurthertherapy.
Heparinized venous blood was collected
from patients at surgery, when available.
Healthy laboratory workers supplied control
blood.
Enzymatic digestion of tumours.-The
general methodology has recently been
extensively described (Haskill, 1981a).
Briefly, tumour material obtained directly
from surgery was placed in cold sterile
saline and maintained on ice until processing.
Scalpel and forceps were used to remove all
normal tissue, and obvious heamorrhagic
tissue. No attempt was made to dissect out
small areas of necrosis contained within the
mass of tumour, which was then gently
diced into small 2mm cubes, washed and
placed in a 100ml bottle containing a 15mm
stirring magnet. To this, 0.14% collagenase
and DNase (Sigma Type I, St Louis, Mo.) in
calcium-and-magnesium-free EDTA-con-
taining PBS were added to at least 4 times the
volume of tumour. The mixture was slowly
stirred for 15-20 min, and the resting
solution gently removed. The process was
usually repeated until the tumour was totally
digested. Each fraction was washed in
medium and held on ice until all the material
was available. Usually the first digestion
contained mostly damaged cells, and subse-
quent material contained predominantly
viable cells ( >95%). When viability was
poor, it was inevitably in the epithelial cells.
Although cell aggregates were frequently
seen in the tumour digests, they were almost
entirely composed of tumour cells. Selective
adherence of mononuclear cells to tumour
cells was not significant.
Sedimentation-velocity separation.-The
methodology has been extensively discussed
in a recent article (Haskill, 1981b) and is
according to the method of Miller &
Phillips (1969). 2 x 106 cells per ml were
applied to the STAPUT chamber in medium
without FCS. Then a 10-20% FCS gradient
was formed under the sample. Sedimentation
was carried out for 2 h at 4°C at 1 g. Two
chamber sizes were used. If the cell number
was <40 x 106, a lOml/mm chamber was
used. If the cell load was >40 x 106, a 22ml/
mm chamber was used. Usually cells were
applied to the chamber directly, without
further fractionation (both tumour and
ascites). When erythrocytes exceeded nuclea-
ted cells more than 3:1, the entire cell
suspension was first separated on Ficoll-
Hypaque.
Cell counts were carried out on each
fraction, velocities determined and fractions
pooled as required. Cell viability exceeded
90%.
Adherence separation of macrophages.-
Macrophages were separated from contami-
nating tumour cells and occasional plasma
cells by adherence. Macrophage-rich fractions
>6 mm/h were allowed to adhere for 30 min
at 37°C in 10% FCS RPMI 1640 medium.
The cells were gently rinsed to remove non-
adherent cells (checked by microscopy) and
then the macrophages were removed by
rinsing vigorously with medium. Viability
exceeded 90% after this procedure. If
tumour cells proved adherent under these
conditions, macrophages were isolated on the
basis of EA RFC properties.
EA RFC separation of macrophages.-In
several cases, either the large macrophages
initially isolated by sedimentation velocity
were poorly adherent to plastic and/or the
tumour cells were highly adherent. In this
situation, rosette formation with IgG-coated
erythrocytes (ox or sheep) for 5 min at 4°C,
followed by rosette isolation over Percol
(Becker & Haskill, 1980a) provided macro-
phages of similar purity to the adherence
technique. Bound erythrocytes were lysed in
0.14% N HCI, 4°C for 1 min. We have never
encountered EARFC clusters associated with
clearly recognizable tumour cells.
Isolation of blood mononuclear cells.-
Blood lymphocytes and monocytes were
routinely isolated on Ficol-Hypaque (Boyum,
1968). Because few cells sedimented > 6-5
mmlh, blood mononuclear cells were not
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routinely separated at 1 g, as for ascites and
tumour-derived inflammatory cells, which
were said to be equivalent to blood mono-
nuclear cells ifthey were in the same velocity
range as blood mononuclear cells.
Immunocytochemical markers
T lymphocytes: E RFC assay.-The per-
centage of E RFC was determined by incu-
bating 2 x 105 test cells with 107 sheep
erythrocytes previously treated with neura-
minidase (Hoffman & Kunkel, 1976). The
cells were incubated at 370C for 10 min and
then centrifuged at 100 g for 5 min and left at
40C overnight. They were gently resuspended
in 1% crystal violet and counted in a haema-
cytometer, or used for cytocentrifuge prepa-
rations without the crystal violet. Four or
more bound erythrocytes were required for
a rosette. At least 200 cells were counted per
sample.
Macrophages: EA RFC assay.-Macro-
phages bearing FcR for IgG can be selectively
detected by the EA RFC assay previously
described, using coated sheep erythrocytes
(SRBC) or ox erythrocytes coated with high
dilutions of antibody (Korn et at., 1978). In
each case 2 x 105 nucleated cells were com-
bined with 107 coated erythrocytes, centri-
fuged at 4°C for 10 min (100 g) and immedi-
ately read as for the E RFC. Control experi-
ments and those reported in Fig. 2a indicated
that lymphocytes forming E RFC are not
detected to a significant level by the use of
coated SRBC, provided that the incubation
time at 40C was restricted to 10 min, and the
optimal dose of antibody was determined by
titration as in our previous report (Korn
et al., 1978). Recently, when only ox RBC
have been used, we have not been able to
detect differences in EA RFC numbers when
either blood or tumour are used.
Blymphocytes:SIg.-Bcellsweresometimes
enumerated using fluoresceinated (Fabl)2
antihuman IgG, IgA, and IgM (Cappel
Laboratories). B lymphocytes were readily
detected in normal blood in this way by
counting the proportion of cells with definite
capping. Monocytes were negative. Mono-
cyte-like cells and macrophages derived from
ascitic and tumour material reacted intensely
with the (Fabl)2 reagent, indicating the pres-
ence of either immune complexes or mono-
meric immunoglobulins. Because of the
difficulty in clearly distinguishing small
macrophages from larger B cells, no attempt
was made to count ascitic B-cell levels
routinely.
Cytochemical stains.-Acid naphthyl-ace-
tate esterase (ANAE) and May-Grrunwald-
Giemsa staining were carried out as described
by Saksela et al. (1979a), acid phosphatase
according to Burstone (1959) and myelo-
peroxidase according to Kaplow (1965).
Cytocentrifuge preparations were immedi-
ately fixed in calcium acetate-formalin
buffer, for all enzyme stains except on
E RFC and EA RFC preparations. These
were allowed to sit at room temperature
overnight before fixation.
RESULTS
Proportions of inflammatory:tumour cells
in ascites and tumours
Ascitic and tumour-derived cell sus-
pensions were analysed for the relative
proportions of lymphocytes, macrophages
and tumour cells. Giemsa-stained cyto-
centrifuge preparations were scored by
standard morphological criteria (Fig. 1).
The results indicate the overwhelming
I-
(1
z
4
0.
0
wI
z
5
4
3
2
ASCITES
FH
9 -
8 -
7 - TUMOAUjR
6 -
- r 2MNH 4- /7 5/9 6/6 SURVIVAL
2- 0/ 2/2 C'- 130 I1 1 I 3 01 31 10
- 30 1:10 3 1:1 3 0:1 30:1 100:1
INFLAMMATORY:TUMOUR CELL RATIO
FOLLOWING ENZYME DISPERSION
FiG. 1.-Relationship between the proportion
ofinflammatory cells (lymphocytes, macro-
phages) and tumour cells in primary
ovarian ascitic fluids and tumour and/
or omental tumour (Stages III and IV).
Standard morphological criteria were used.
Survival data indicate that patients whose
solid tumours contained a higher inflam-
matory response responded to chemo.
therapy (Adriamycin, Alkeran). Granulo-
cytes were rarely isolated from either
source, but were commonly found in
pleural effusions (not shown).
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preponderance of inflammatory cells in
ovarian ascites derived from patients not
undergoing therapy. In contrast, lympho-
cytes and macrophages seldom exceeded
the number oftumour cells recovered from
enzymatically dispersed tumour tissue.
Numerous attempts were made to quan-
titate inflammatory-cell proportions using
rosette assays on unseparated disag-
gregated material. E RFC assays were
found to be unreliable presumably because
of interference with the cell debris as-
sociated with the unseparated material,
the low lymphocyte proportions and the
difficulty in pelleting the SRBCs in the
proper levels with the lymphocytes when
cells ofvarious sizes were present together.
Relationship between inflammation and
response to therapy
A striking feature of this part of the
study was that patients in whom in-
flammatory cells were common (ovary
and/or omentum) inevitably responded to
standard forms ofchemotherapy (survival
longer than 12 months) (Fig. 1). Because
of the small number of patients involved
it was not possible to subdivide them
further according to the particular chemo-
therapy used, residual tumour burden
or differentiation of the tumour. These
data are provided as a preliminary
indication that infiltration is somehow
related to a response to chemotherapy,
and that a thorough analysis of the func-
tional properties of these inflammatory
cells would be justified.
Sedimentation velocity separation of ascites
and tumour material
Our separation approach was designed
around three features. First, we did not
wish to bias our experiments by selecting
a particular inflammatory-cell type early
in the analysis. Thus we chose a method
which selected predominantly on the
basis of size. Second, as we wished to
compare systemic and in situ immune
responses, tumour and ascites-infiltrating
cells had to be isolated in as similar a way
as possible to the same cells isolated
from blood. Finally, these fractions would
haveto befreeoftumour cells. Fortunately
in few cases of highly differentiated
adenocarcinoma (not used in this study)
were tumour cells similar in velocity to
the largest, most rapidly sedimenting
inflammatory cells (< 6 mm/h). Fig. 2
demonstrates separations achieved with
normal blood, ascites and tumour-derived
material (different donors). The various
proportions of inflammatory and tumour
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FIG. 2.-Sedimentation-velocity profiles for
the various types of cell in normal blood,
ascites (chosen as an example most similar
to blood) and a solid tumour containing a
high proportion of mononuclear cells. The
results indicate that E RFC seldom sedi-
ment > 6 mm/h and that there are different
proportions of small ( < 4-5 mm/h) large
(4-5-6-0 mm/h) T cells in ascites and
tumour samples. The EA RFC profiles
clearly indicate that most E RFC+ cells do
not recognize the sheep EA RFC reagent.
Tumour cells in the ascites sample were
in clusters which sedimented faster than
the mononuclear cells. Cell classification:
O O,total. D C,E RFC.@ 0*,
EA. * *, SIg. A----A, Tumour.
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cells were quantified in each fraction.
The results show that blood-like in-
flammatory cells can be isolated from
ascites and tumour material, provided
that velocity fractions are < 6 mm/h. By
selecting cells sedimenting at <6 mm/h,
we did not recover blast-like lymphocytes.
However, as these were relatively in-
frequent and in any event were absent
from both normal and patient blood, the
comparison between blood, ascites and
tumour was still valid. Rapidly sedi-
menting macrophages (> 6 mm/h) as dis-
tinct from blood monocytes, were subse-
quently isolated by adherence or EA-
rosette depletion from the contaminating
tumour cells in the high velocity regions.
Variation in inflammatory pattern between
tumour and ascitic material of the patient
and between differentpatients
The variation in sedimentation-velocity
profiles of ascites and tumour-cell sus-
pensions, both within individual patients
and between patients, was marked. One
example is given in Fig. 3. The tumour-
derived material was composed mostly
of tumour cells; T lymphocytes and
macrophages were present in similar
proportions. In the ascites, however, few
tumour cells were detected. Most of the
cells were large macrophages which could
be separated into two classes on the basis
of sedimentation velocity and myelo-
peroxidase andacid-phosphatase reactions
Although the tumour contained macro-
phages similar in velocity to those present
in the lower velocity region of the ascites
sample (.< 8 mm/h), the cytochemical dif-
ferences were marked. Twenty per cent of
tumour-derived macrophages were weakly
peroxidase-positive, whereas 60% ofascitic
macrophages stained intensely. Although
tumour macrophages reacted with the
acid-phosphatase reagent after 1 h, ascitic
macrophages stained brilliantly within
10 min, indicating marked quantitative
differences. Finally, many of the highest-
velocity macrophages in the ascites sample
had ingested neutrophils and/or lympho-
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FIG. 3.-Sedimentation-velocity profiles for
total cells, E and EA RFCS derived from
both the primary tumour and ascites of a
patient with Stage III adenocarcinoma of
the ovary. Differences in the E and EA RFC
profiles are apparent. Acid phosphatase
(AP) and myeloperoxidase (MPer) stains
were used on the adherence-purified
macrophage fractions (6-5-7.5 mm/h and
9-11-5 mm/h). Onlythelow-velocity macro-
phages in the ascites sample reacted inten-
sely for peroxidase, whereas the high-
velocity ascitic macrophages reacted inten-
sely for acid phosphatase. Cytochemical
data were based on macrophage counts in
each fraction determined morphologically.
Most of the cells sedimenting faster than
6 mm/h in the tumour sample were tumour
cells. Single tumour cells were 1% of the
total in the ascites. (0 O, total cells.
0 0I,E RFC.* *,EA RFC).
cytes and other cellular debris. The T
lymphocytes in the ascites were also
heterogeneous. A sizeable proportion sedi-
mented up to 8 mm/h, a value in keeping
with the characteristics of dividing or
blast lymphocytes.
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These data suggest that heter(
within both T-lymphocyte and m
macrophage populations exists bot
tumour and ascites material fro
vidual patients, and between
(cf. Figs 2 & 3).
Characterization ofinfiltration: lym
monocytefraction
The cell isolation outlined ab(
performed on the series of patier
adenocarcinoma of the ovary
to in Fig. 1. For technical and I
reasons, not all cell-maker assa;
carried out on each patient or cell i
In particular, B-cell assays w
frequent. SIg values were usually
to determine as ascites and
derived monocyte-macrophge c
acted strongly with the (Fabl)2
even when there was no reactio
normal blood monocytes.
The results (Fig. 4) indicate
points which are important in esta
the usefulness of our methodol
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iated with blood and blood-equiv
fractions isolated from solid and aQ
ovarian tumours. Tumour-derived mal
was isolated by sedimentation vel
Cells were chosen for values <6 m
(E) E RFC; (Eest) E RFC stained
ANAE (plotted as % of E RFC); (EA
RFC, (NSE) monocytes stained with
specific esterase reagent and (SIg) B
fluorescein-conjugated anti HulgG, 2
reagent. Bars represent the mean of
column.
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ogeneity isolating tumour and ascitic inflammatory
Dnocyte- cells. First, both ascitic and tumour-
,hwithin infiltrating cells (< 6 mm/h) had T-cell
m indi- values which averaged at least as high as
patients normal or patient blood. Second, the
T-cell subset identified on the basis of
ANAE staining ofE RFCpreparations was
tphocyte- abnormallylowinfrequencyinthetumour
derived material. Third, monocyte levels
ove was assessed by nonspecific-esterase staining nts with were usually much lower in the ascitic
referred fraction than in the other groups. Fourth,
practical FcR rosette assays, which detected mono-
ys were cytes only in blood, (Fig. 2, top) were
fraction. markedly higher in patient material,
rere in- and apparently measured either esterase-
difficult negative monocytes and/or lymphocytes
tumour- with abnormally high FcR levels, Finally,
ells re- plasma cells were rarely seen in either
reagent ascites or tumour material. In summary,
in with' the marker studies indicated that the
fractionation procedure yields prepara-
several tions adequate for comparison with blood-
blishing derived cells for tests of immune com-
[ogy for petance, though the proportions of the
various cell types vary greatly between
TUMOUR patients. The use of collagenase on all
the solid-tumour material and several
of the ascites which had gelled is un-
likely to have had any effect on these
results as we (Haskill et al., 1982; Hayry
& Totterman, 1978) have shown this
enzyme to be without marked influence
on either functional or membrane studies.
* -*-* Characterization ofinfiltration: macrophage
fraction
Cells sedimenting more rapidly than
6 mm/h were pooled on the basis of EA
.S,EANSE SIg RFC distribution, and a macrophage
ISSOC- fraction isolated either by EA RFC alent separation or adherence. The data sum- csites marized in Fig. 5 indicate: first, that
teriial highly enriched fractions of macrophages
im/h. can lre isolated from both ascitic and with tumour material; second, only in a few .) EA
non- instances are the macrophages composed with of recently arrived peroxidase-positive
ea M monocytes; and third, tumour macro-
phages are less often peroxidase-positive
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00ASCITES * TUOR often difficult. One of the commonest
so 0::
S*. * : problems is the preselection of effector
0@ 00 001 0
800 _ ** *- cell types by cell-fractionation procedures,
. . . * e.g. nylon-wool columns, adherence, and
60_ * * Ficoll-Hypaque density gradients. We
have previously demonstrated the value
40_ * of sedimentation velocity at unit gravity
: * . in isolating all the tumour and tumour-
20 *- 0 infiltrating cells after dispersion in collage-
* nase DNase (Haskill et al., 1979; Becker
EA MXer NSE AP EA M Pe NSE & Haskill, 1980b). Velocity fractions
EA MPer NSE AP EA MPer NSE AP selected for size equivalence to blood-
iG. 5.-Immunocytochemical markers assoc derived cells permit testing for a wide
iated with macrophage fractions isolated variety of potential effector cell types.
from solid and ascites ovarian tumours. In this way, the function of blood-
Cells sedimenting > 6 mm/h were further fractionated by adherence or EA RFC e
removal. EA RFC (EA), myeloperoxidase identification of the particular cell type
(MPer), nonspecific esterase (NSE), and or sub-class associated with this activity.
acid phosphatase (AP). Our results are based upon cell fractions
which are as representative a mixture
in those in the ascites, and show a as possible of all the inflammatory cells.
greater variation in reactivity for Thus, apparent differences between our
tdphosphatase. data and others probably result from
differences in isolation sequences.
DISCUSSION A number of groups have investigated
both cytological and functional activity
Histological grade, stage, and amount of inflammatory cells in either tumour
residual tumour are likely to be the or ascites-derived material from a variety
)st important prognostic indicators. of human tumours. Several features of
)wever, there is considerable evidence, these reports warrant discussion, in view
th in animal models and clinical of our subsequent reports concerning
idies, that the degree of mononuclear- functional activity associated with these
1 infiltration may be relevant to survival. fractions.
cently there has been an increase in Klein et al. (1980) have made an exten-
erest in the possible functions of sive study of lymphocyte function in a
mune cells isolated from solid tumours. number of types of human tumours.
though a variety of effector mechanisms Using a combination of approaches, in
wluding ADCC, NK, CTL, cytostatic volving velocity, density and adherence,
d cytolytic macrophages have been for cell isolation, these authors isolated
lated from highly immunogenic animal lymphoid fractions which averaged 51%
mours (Russell et al., 1980; Haskill E RFC and 220% EA RFC cells for their
al., 1979; Herberman et al., 1980), functional studies. They seldom encounter-
:re are fewer instances where active ed B lymphocytes in these preparations.
Is have been isolated from human Hayry & Totterman (1978) have in-
mours (Mantovani et al., 1979; Werk- vestigated the types of cell infiltrating
ister et al., 1979; Totterman et al., several classes of human tumour, in-
80; Klein et al., 1980; Herberman et al., cluding two with ovarian cancer. Infil-
30; and Vose, 1978). trating cells were isolated through a
[solation of a representative sample of series of steps similar to those described
lammatory cells from tumour and in this report. T cells, monocytes and
itic material for functional studies is macrophages, polymorplis and plasma
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cells were common isolates of these
tumours, and there was considerable
variation between tumours. The values
for the percentage of T cells varied from
35% for several tumour classes to 83%
for 3 seminoma patients. The ANAE
T-cell subset was the most prominent
subset in the isolate.
Recently Mantovani et al. (1980b) have
reported their findings on NK activity
associated with malignant effusions of the
ovary. Enriched preparations of ascites-
associated lymphocytes were obtained by
stepwise density and velocity separations
similar to those used by Vose et al. (1977)
followed by repeated adherence steps or
discontinuous Ficoll-Hypaque gradients.
The percentage of lymphoid cells forming
E RFC (39%) averaged less than that in
either blood from patients or normal
blood. In contrast, the values we have
found for E RFC in similar fractions
average 78%. The 2-fold difference does
not appear to be related to the E RFC
assay, as values for normal and patient
bloods are similar to ours.
This report demonstrates that mono-
nuclear cell fractions containing > 70%
T cells are routinely obtained by sedimen-
tation-velocity separation of collagenase-
dispersed tumours. Similar separations on
ascitic material yielded mostly T cells.
Our data however, indicate differences in
the T-cell characteristics ofthese fractions.
Several studies have clearly demonstrated
that T cells can be further subdivided by a
highly localized esterase "dot" staining
on E RFC preparations (ANAE positivity)
(Saksela et al., 1979a; Moretta et al., 1979;
Bevan et al., 1980). We have found that
the T subset characterized by ANAE
reactivity was noticeably smaller in the
tumour infiltrate than in patient blood
or ascites. Whether this indicates a
selective localization or degranulation
in vivo (Moretta et al., 1979) is not known.
Thisresult may, however, provide evidence
of a preferential subset localization in
ovarian tumours.
The present study also clearly indi-
cates the heterogeneity ofthe macrophage
component oftumour and ascites prepara-
tions. Esterase-positive monocyte-sized
macrophages were frequently absent from
ascites isolates, but were commonly found
in tumour-derived material. In contrast,
macrophages high in esterase and acid-
phosphatase but low in myeloperoxidase
activity were isolated from the higher-
velocity fractions. These cells varied
greatly between patients in their per-
oxidase and acid-phosphatase activity.
In addition, many of the larger ascites
macrophages containedphagocytosed leuc-
cytes. Tumour-derived macrophages fre-
quently contained debris, but were seldom
peroxidase-positive, and usually had less
acid phosphatase. This variation between
patients will undoubtedly explain in
part the variation in cytolytic activity
reported for ascites macrophages derived
from ovarian-cancer patients (Mantovani
et al., 1980a) and serves as an indication
that quantitative and qualitative dif-
ferences in infiltration must be taken into
account in assessing intra-tumour immune
reactivity.
In the accompanying reports, the NK,
ADCC, PHA and suppressor-cell responses
ofthe mononuclear cell fractions described
above will be outlined. These data
indicate the frequent dissociation between
systemic and in situ immunity, as well
as the decreased reactivity of some
classes oftumour-infiltrating cells isolated
from ovarian cancers.
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